Chaise Murphy1,2, Karsten Koehler3,4. 1. Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA. 2. Department of Sport and Health Sciences, Technical University of Munich, Uptown München-Campus D, Georg-Brauchle-Ring 60/62, 80992, München, Germany. 3. Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA. karsten.koehler@tum.de. 4. Department of Sport and Health Sciences, Technical University of Munich, Uptown München-Campus D, Georg-Brauchle-Ring 60/62, 80992, München, Germany. karsten.koehler@tum.de.
Abstract
PURPOSE:Weight loss can result in the loss of muscle mass and bone mineral density. Resistance exercise is commonly prescribed to attenuate these effects. However, the anabolic endocrine response to resistance exercise during caloric restriction has not been characterized. METHODS: Participants underwent 3-day conditions of caloric restriction (15 kcal kg FFM-1) with post-exercise carbohydrate (CRC) and with post-exercise protein (CRP), and an energy balance control (40 kcal kg FFM-1) with post-exercise carbohydrate (CON). Serial blood draws were taken following five sets of five repetitions of the barbell back squat exercise on day 3 of each condition. RESULTS: In CRC and CRP, respectively, growth hormone peaked at 2.6 ± 0.4 and 2.5 ± 0.9 times the peak concentrations observed during CON. Despite this, insulin-like growth factor-1 concentrations declined 18.3 ± 3.4% in CRC and 27.2 ± 3.8% in CRP, which was greater than the 7.6 ± 3.6% decline in CON, over the subsequent 24 h. Sclerostin increased over the first 2 days of each intervention by 19.2 ± 5.6% in CRC, 21.8 ± 6.2% in CRP and 13.4 ± 5.9% in CON, but following the resistance exercise bout, these increases were attenuated and no longer significant. CONCLUSION: During caloric restriction, there is considerable endocrine anabolic resistance to a single bout of resistance exercise which persists in the presence of post-exercise whey protein supplementation. Alternative strategies to restore the sensitivity of insulin-like growth factor-1 to growth hormone need to be explored.
RCT Entities:
PURPOSE:Weight loss can result in the loss of muscle mass and bone mineral density. Resistance exercise is commonly prescribed to attenuate these effects. However, the anabolic endocrine response to resistance exercise during caloric restriction has not been characterized. METHODS:Participants underwent 3-day conditions of caloric restriction (15 kcal kg FFM-1) with post-exercise carbohydrate (CRC) and with post-exercise protein (CRP), and an energy balance control (40 kcal kg FFM-1) with post-exercise carbohydrate (CON). Serial blood draws were taken following five sets of five repetitions of the barbell back squat exercise on day 3 of each condition. RESULTS: In CRC and CRP, respectively, growth hormone peaked at 2.6 ± 0.4 and 2.5 ± 0.9 times the peak concentrations observed during CON. Despite this, insulin-like growth factor-1 concentrations declined 18.3 ± 3.4% in CRC and 27.2 ± 3.8% in CRP, which was greater than the 7.6 ± 3.6% decline in CON, over the subsequent 24 h. Sclerostin increased over the first 2 days of each intervention by 19.2 ± 5.6% in CRC, 21.8 ± 6.2% in CRP and 13.4 ± 5.9% in CON, but following the resistance exercise bout, these increases were attenuated and no longer significant. CONCLUSION: During caloric restriction, there is considerable endocrine anabolic resistance to a single bout of resistance exercise which persists in the presence of post-exercise whey protein supplementation. Alternative strategies to restore the sensitivity of insulin-like growth factor-1 to growth hormone need to be explored.
Entities:
Keywords:
Energy availability; Energy deficit; Growth hormone; Sclerostin; Strength training; Weightlifting
Authors: Lawrence E Armstrong; Amy C Pumerantz; Kelly A Fiala; Melissa W Roti; Stavros A Kavouras; Douglas J Casa; Carl M Maresh Journal: Int J Sport Nutr Exerc Metab Date: 2010-04 Impact factor: 4.599
Authors: K E Ensrud; T N Vo; A J Burghardt; J T Schousboe; J A Cauley; B C Taylor; A R Hoffman; E S Orwoll; N E Lane; L Langsetmo Journal: Osteoporos Int Date: 2018-03-23 Impact factor: 4.507
Authors: Reina Armamento-Villareal; Corinn Sadler; Nicola Napoli; Krupa Shah; Suresh Chode; David R Sinacore; Clifford Qualls; Dennis T Villareal Journal: J Bone Miner Res Date: 2012-05 Impact factor: 6.741
Authors: Tasha Lp Ballard; Jeffrey A Clapper; Bonny L Specker; Teresa L Binkley; Matthew D Vukovich Journal: Am J Clin Nutr Date: 2005-06 Impact factor: 7.045
Authors: José L Areta; Louise M Burke; Donny M Camera; Daniel W D West; Siobhan Crawshay; Daniel R Moore; Trent Stellingwerff; Stuart M Phillips; John A Hawley; Vernon G Coffey Journal: Am J Physiol Endocrinol Metab Date: 2014-03-04 Impact factor: 4.310
Authors: John W Carbone; Stefan M Pasiakos; Lisa M Vislocky; Jeffrey M Anderson; Nancy R Rodriguez Journal: Appl Physiol Nutr Metab Date: 2014-06-19 Impact factor: 2.665
Authors: Reina Armamento-Villareal; Lina Aguirre; Debra L Waters; Nicola Napoli; Clifford Qualls; Dennis T Villareal Journal: J Bone Miner Res Date: 2019-12-04 Impact factor: 6.741
Authors: Kristen M Beavers; Daniel P Beavers; Sarah B Martin; Anthony P Marsh; Mary F Lyles; Leon Lenchik; Sue A Shapses; Barbara J Nicklas Journal: J Gerontol A Biol Sci Med Sci Date: 2017-10-12 Impact factor: 6.053
Authors: Eimear Dolan; Alina Dumas; Karen M Keane; Giulia Bestetti; Luisa Helena Mavalli Freitas; Bruno Gualano; Wendy M Kohrt; George A Kelley; Rosa Maria Rodrigues Pereira; Craig Sale; Paul A Swinton Journal: Sports Med Date: 2022-07-23 Impact factor: 11.928
Authors: Stephen J Keenan; Matthew B Cooke; Ebrahim Bani Hassan; Won Sun Chen; Josef Sullivan; Sam X Wu; Doa El-Ansary; Mahdi Imani; Regina Belski Journal: Eur J Nutr Date: 2022-01-27 Impact factor: 4.865
Authors: Rebekah L Wilson; Robert U Newton; Dennis R Taaffe; Nicolas H Hart; Philippa Lyons-Wall; Daniel A Galvão Journal: Med Sci Sports Exerc Date: 2021-03-01